Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.6110
0.00 (0.00%)
At close: Oct 9, 2026
Sequana Medical NV Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | - | 0.11 | 0.71 | 0.92 | 0.37 | 0.96 |
Revenue Growth | - | -85.19% | -22.81% | 149.04% | -61.54% | -0.76% |
Gross Profit Gross Profit Growth | -0 | 0.08 | 0.55 | 0.72 | 0.29 | 0.76 |
Operating Income Operating Income Growth | -17.94 | -18.71 | -29.49 | -28.62 | -23.82 | -17.77 |
Net Income Net Income Growth | -51.85 | -44.65 | -32.56 | -30.76 | -23.62 | -19.11 |
Earnings Per Share EPS Growth | -1.11 | -1.22 | -1.22 | -1.35 | -1.30 | -1.25 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Germany Germany Growth | 0.09 | 0.55 | 0.69 | 0.32 | 0.69 |
France France Growth | 0.02 | 0.1 | 0.11 | 0.04 | 0.17 |
Switzerland Switzerland Growth | - | 0.04 | 0.09 | 0.02 | 0.06 |
Rest of The World Rest of The World Growth | - | 0.02 | 0.03 | - | 0.04 |
Total Total Growth | 0.11 | 0.71 | 0.92 | 0.37 | 0.96 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 7.31 | 3.81 | 2.58 | 18.87 | 9.6 | 11.02 |
Total Debt Total Debt Growth | 41.4 | 40.11 | 17.52 | 17.59 | 8.09 | 7.86 |
Net Cash (Debt) Net Cash Growth | -34.09 | -36.3 | -14.94 | 1.28 | 1.52 | 3.16 |
Net Cash Growth | - | - | - | -15.34% | -52.00% | 33.66% |
Net Cash Per Share Net Cash Per Share Growth | -0.73 | -0.99 | -0.56 | 0.06 | 0.08 | 0.21 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -17.63 | -20.26 | -29.06 | -27.48 | -23.62 | -17.01 |
Capital Expenditures CapEx Growth | -0.07 | -0.1 | -0.71 | -0.68 | -0.33 | -0.14 |
Free Cash Flow Free Cash Flow Growth | -17.69 | -20.35 | -29.77 | -28.16 | -23.94 | -17.14 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | - | 74.94% | 76.95% | 77.83% | 79.31% | 78.99% |
Operating Margin | - | -17731.38% | -4141.06% | -3102.32% | -6428.78% | -1844.86% |
Pretax Margin | - | -42059.94% | -4507.05% | -3292.17% | -6267.69% | -1967.15% |
Profit Margin | - | -42325.70% | -4572.43% | -3334.08% | -6373.84% | -1983.45% |
FCF Margin | - | -19292.21% | -4180.74% | -3051.80% | -6462.39% | -1779.67% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Forward PE | - | 2.14 | 2.14 | 2.14 | - | - |
PS Ratio | - | 1288.86 | 158.63 | 154.42 | 379.06 | 193.28 |